GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Euroespes SA (XMAD:EEP) » Definitions » Total Liabilities

Euroespes (XMAD:EEP) Total Liabilities : €5.22 Mil (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Euroespes Total Liabilities?

Euroespes's Total Liabilities for the quarter that ended in Dec. 2022 was €5.22 Mil.

Euroespes's quarterly Total Liabilities increased from Dec. 2021 (€4.82 Mil) to Jun. 2022 (€5.23 Mil) but then declined from Jun. 2022 (€5.23 Mil) to Dec. 2022 (€5.22 Mil).

Euroespes's annual Total Liabilities increased from Dec. 2020 (€4.26 Mil) to Dec. 2021 (€4.82 Mil) and increased from Dec. 2021 (€4.82 Mil) to Dec. 2022 (€5.22 Mil).


Euroespes Total Liabilities Historical Data

The historical data trend for Euroespes's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroespes Total Liabilities Chart

Euroespes Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.96 3.92 4.26 4.82 5.22

Euroespes Semi-Annual Data
Dec12 Jun13 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.26 4.79 4.82 5.23 5.22

Euroespes Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Euroespes's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.543+(2.597+0.08
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=5.22

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=11.42-6.2
=5.22

Euroespes's Total Liabilities for the quarter that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.543+(2.597+0.08
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=5.22

Total Liabilities=Total Assets (Q: Dec. 2022 )-Total Equity (Q: Dec. 2022 )
=11.42-6.2
=5.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroespes Total Liabilities Related Terms

Thank you for viewing the detailed overview of Euroespes's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroespes (XMAD:EEP) Business Description

Traded in Other Exchanges
N/A
Address
Santa Marta de Babio, Bergondo, La Coruna, ESP, 15165
Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.